Naive CD4+ T cells from patients with SS were treated under Th17- or Treg-polarizing conditions, and administration of IL-27 suppressed the differentiation of Th17 cells and increased the percentage of Treg cells (131). The gene discussed is CD4; the disease is synovial sarcoma.